Could psychedelics make you more creative? Shift your mind, connect you to others, and help you access a younger, more malleable version of yourself? Activist Rick Doblin, neuroscientist Gül Dölen, and musician Reggie Watts join Brian Greene for a mind-bending and multidisciplinary conversation about the promises and pitfalls of these "magic" molecules and their impact on creativity, connection, and consciousness.
This program is part of the Big Ideas series, supported by the John Templeton Foundation.
Read moreThere is still no definitive evidence that microdosing with psychedelics is either effective or safe. Keep reading to read the potential benefits and risks.
Read moreNew research finds LSD effective in decreasing anxiety and depression.
Researchers report “effects were maximal 2 weeks after the second LSD session and sustained up to 16 weeks.”
Read moreAccording to a new survey conducted by researchers at Johns Hopkins Medicine, published Aug. 24 in the journal PLOS ONE, people’s attitudes about death change after both a psychedelic drug experience and a non-drug-related out-of-body experience.
People were less afraid of death than they had been before their experiences.
Read moreIs it all hype or is there genuine hope for therapeutic application of microdosing?
There’s certainly plenty of ‘conflicting’ information or results available from studies of different methodologies. Here, we begin with an overview of what microdosing is, who does it, and for what purposes. We then review available evidence and summarize benefits and risks of microdosing. Finally, we get more practical and discuss microdosing regimens, measurement of accurate dosing, and ‘set and setting’ consideration to microdosing.
Read moreNew research reveals that the psychedelic compound in magic mushrooms, in combination with talk therapy, could be a promising treatment for people with alcohol addiction.
In a study published Wednesday in JAMA Psychiatry, scientists found that patients taking this drug, called psilocybin, had an 83 percent decline in heavy drinking, while those who took a placebo experienced a 51 percent decline.
Read moreCU Cancer Center researchers are collaborating on NCI-funded research to understand the effects of psilocybin on the depression and anxiety that people with cancer can feel.
Read more